Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan
Hepatitis C virus (HCV) affects at least 268,000 Canadians and causes greater disease burden than any other infectious disease in the country. The Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC) have identified HCV-related liver disease as a priority. In 2...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2016/5743521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552400977657856 |
|---|---|
| author | Selena M. Sagan Benoit Dupont Jason Grebely Mel Krajden Sonya A. MacParland Jennifer F. Raven Sahar Saeed Jordan J. Feld D. Lorne Tyrrell Joyce A. Wilson |
| author_facet | Selena M. Sagan Benoit Dupont Jason Grebely Mel Krajden Sonya A. MacParland Jennifer F. Raven Sahar Saeed Jordan J. Feld D. Lorne Tyrrell Joyce A. Wilson |
| author_sort | Selena M. Sagan |
| collection | DOAJ |
| description | Hepatitis C virus (HCV) affects at least 268,000 Canadians and causes greater disease burden than any other infectious disease in the country. The Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC) have identified HCV-related liver disease as a priority. In 2015, the release of well-tolerated, short course treatments (~12 weeks) able to cure the majority of treated HCV patients revolutionized HCV therapy. However, treatment is extremely costly and puts a significant burden on the Canadian healthcare system. Thus, managing treatment costs and improving treatment engagement in those most in need will be a key challenge. Diagnosis and treatment uptake are currently poor in Canada due to financial, geographical, cultural, and social barriers. The United States, Australia, and Scotland all have National Action Plans to prevent, diagnose, and treat HCV in order to efficiently reduce the burden and costs associated with HCV-related liver disease. The theme of the 4th annual symposium held on Feb 27, 2015, “Strategies to Manage HCV Infection in Canada: Moving towards a National Action Plan,” was aimed at identifying strategies to maximize the impact of highly effective therapies to reduce HCV disease burden and ultimately eliminate HCV in Canada. |
| format | Article |
| id | doaj-art-e18bd4232f7c4c27a0ff92cf23147dcc |
| institution | Kabale University |
| issn | 2291-2789 2291-2797 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology and Hepatology |
| spelling | doaj-art-e18bd4232f7c4c27a0ff92cf23147dcc2025-02-03T05:58:54ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972016-01-01201610.1155/2016/57435215743521Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action PlanSelena M. Sagan0Benoit Dupont1Jason Grebely2Mel Krajden3Sonya A. MacParland4Jennifer F. Raven5Sahar Saeed6Jordan J. Feld7D. Lorne Tyrrell8Joyce A. Wilson9Department of Microbiology & Immunology, McGill University, Montréal, QC, H3A 2B4, CanadaLiver Unit, Department of Medicine, Université de Montréal, Montréal, QC, H3T 1J4, CanadaThe Kirby Institute, UNSW Australia, Sydney, NSW 2052, AustraliaBritish Columbia Centre for Disease Control, Vancouver, BC, V5Z 4R4, CanadaToronto General Research Institute, University Health Network, Toronto, ON, M5G 1L7, CanadaCanadian Institutes of Health Research-Institute of Infection and Immunity, Ottawa, ON, K1A 0W9, CanadaDepartment of Epidemiology, McGill University, Montréal, QC, H3A 1A2, CanadaToronto Western Hospital Liver Center, University Health Network, Toronto, ON, M5T 2S8, CanadaLi Ka Shing Institute of Virology, Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB, T6G 2E1, CanadaDepartment of Microbiology & Immunology, University of Saskatchewan, Saskatoon, SK, S7N 5E5, CanadaHepatitis C virus (HCV) affects at least 268,000 Canadians and causes greater disease burden than any other infectious disease in the country. The Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC) have identified HCV-related liver disease as a priority. In 2015, the release of well-tolerated, short course treatments (~12 weeks) able to cure the majority of treated HCV patients revolutionized HCV therapy. However, treatment is extremely costly and puts a significant burden on the Canadian healthcare system. Thus, managing treatment costs and improving treatment engagement in those most in need will be a key challenge. Diagnosis and treatment uptake are currently poor in Canada due to financial, geographical, cultural, and social barriers. The United States, Australia, and Scotland all have National Action Plans to prevent, diagnose, and treat HCV in order to efficiently reduce the burden and costs associated with HCV-related liver disease. The theme of the 4th annual symposium held on Feb 27, 2015, “Strategies to Manage HCV Infection in Canada: Moving towards a National Action Plan,” was aimed at identifying strategies to maximize the impact of highly effective therapies to reduce HCV disease burden and ultimately eliminate HCV in Canada.http://dx.doi.org/10.1155/2016/5743521 |
| spellingShingle | Selena M. Sagan Benoit Dupont Jason Grebely Mel Krajden Sonya A. MacParland Jennifer F. Raven Sahar Saeed Jordan J. Feld D. Lorne Tyrrell Joyce A. Wilson Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan Canadian Journal of Gastroenterology and Hepatology |
| title | Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan |
| title_full | Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan |
| title_fullStr | Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan |
| title_full_unstemmed | Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan |
| title_short | Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan |
| title_sort | highlights of the fourth canadian symposium on hepatitis c moving towards a national action plan |
| url | http://dx.doi.org/10.1155/2016/5743521 |
| work_keys_str_mv | AT selenamsagan highlightsofthefourthcanadiansymposiumonhepatitiscmovingtowardsanationalactionplan AT benoitdupont highlightsofthefourthcanadiansymposiumonhepatitiscmovingtowardsanationalactionplan AT jasongrebely highlightsofthefourthcanadiansymposiumonhepatitiscmovingtowardsanationalactionplan AT melkrajden highlightsofthefourthcanadiansymposiumonhepatitiscmovingtowardsanationalactionplan AT sonyaamacparland highlightsofthefourthcanadiansymposiumonhepatitiscmovingtowardsanationalactionplan AT jenniferfraven highlightsofthefourthcanadiansymposiumonhepatitiscmovingtowardsanationalactionplan AT saharsaeed highlightsofthefourthcanadiansymposiumonhepatitiscmovingtowardsanationalactionplan AT jordanjfeld highlightsofthefourthcanadiansymposiumonhepatitiscmovingtowardsanationalactionplan AT dlornetyrrell highlightsofthefourthcanadiansymposiumonhepatitiscmovingtowardsanationalactionplan AT joyceawilson highlightsofthefourthcanadiansymposiumonhepatitiscmovingtowardsanationalactionplan |